TSLA
Tesla
-- 421.060 NVDA
NVIDIA
-- 134.700 PLTR
Palantir
-- 80.550 AMD
Advanced Micro Devices
-- 119.210 QUBT
Quantum Computing
-- 17.620 
NEWS
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
FibroBiologics (Nasdaq: FBLG) has filed a patent application for an adhesive bandage using fibroblast cell-based technology for wound healing. This innovative approach aims to leverage the healing properties of fibroblasts in a stable, room-temperature bandage suitable for post-surgical and retail use. The company, which focuses on developing therapeutics for chronic diseases using fibroblasts, sees this as an opportunity to expand its wound care platform and make advanced treatments more accessible.
CEO Pete O'Heeron highlighted the potential for a shelf-stable bandage, while CSO Hamid Khoja, Ph.D., emphasized the transformative potential of fibroblasts in wound care. With over 160 patents issued and pending, FibroBiologics continues to explore novel applications of fibroblast technology in healthcare.
CEO Pete O'Heeron highlighted the potential for a shelf-stable bandage, while CSO Hamid Khoja, Ph.D., emphasized the transformative potential of fibroblasts in wound care. With over 160 patents issued and pending, FibroBiologics continues to explore novel applications of fibroblast technology in healthcare.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
JACKIE 136 : Very good recommendation, buy some and try